Developing the First Non-Injectable Botulinum Toxin
Revance Therapeutics is a clinical stage specialty pharmaceutical company developing botulinum toxin products that will change the botulinum toxin landscape in aesthetic and therapeutic dermatology. The company’s lead investigational product is a topical formulation of botulinum toxin type A (BoNTA) with a broad pipeline of potential indications. It has the potential to provide a painless alternative to existing treatments.
Learn more >